Electric field device takes on pancreatic cancer in new trial

NCT ID NCT07284277

Recruiting now Disease control Sponsor: Clinica Universidad de Navarra, Universidad de Navarra Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a wearable device that creates electric fields (TTFields) combined with chemotherapy for people with metastatic pancreatic cancer. The device is worn at home for at least 18 hours a day and aims to disrupt cancer cell division. The trial will check if the combination is safe and if patients can stick with the treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Tumor Treating Fields (TTFields) device plus chemotherapy (modFOLFIRINOX)
What this could lead to: If it works, this could offer a new treatment option for metastatic pancreatic cancer by combining a wearable device with standard chemo.
What could go wrong: This is an early-phase trial with only 30 participants, so results may not apply broadly. The device must be worn at least 18 hours daily, which may be burdensome.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PANCREATIC ADENOCARCINOMA METASTATIC are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

pancreatic adenocarcinoma pancreatic ductal adenocarcinoma pancreatic neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PANCREATIC ADENOCARCINOMA METASTATIC PANCREATIC DUCTAL ADENOCARCINOMA

Contacts and locations

Locations

Clínica Universidad de Navarra
RECRUITING

Pamplona, Navarre, 31008, Spain
Fundación Jiménez-Díaz
NOT_YET_RECRUITING

Madrid, 28040, Spain
Hospital Universitario de Araba
NOT_YET_RECRUITING

Vitoria-Gasteiz, Álava, 01009, Spain
Hospital Universitario de Cruces
NOT_YET_RECRUITING

Barakaldo, Vizcaya, 48903, Spain
Hospital de Galdakao
NOT_YET_RECRUITING

Galdakao, Vizcaya, 48960, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.